| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sab Biotherapeutics, Inc. (SABS) has 15 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. SABS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 4.80M | $18.48M | - | |
| Pres | 3.00M | $11.55M | - | |
| Dir | 2.20M | $8.46M | - | |
| Other | 1.20M | $4.62M | - | |
| COO | 600.0K | $2.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 14, 2021 | Katz Ilan | Director, 10% Owner | Buy | 417,200 | $10.00 | $4,172,000.00 | +15.9% | |
| Jan 14, 2021 | Reich Samuel J | CEO And CFO | Buy | 417,200 | $10.00 | $4,172,000.00 | +15.9% | |
| Jan 14, 2021 | Big Cypress Holdings LLC | CEO And CFO | Buy | 417,200 | $10.00 | $4,172,000.00 | +15.9% |